GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » EBITDA Margin %

Eusol Biotech Co (ROCO:6652) EBITDA Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Eusol Biotech Co's EBITDA for the six months ended in Jun. 2024 was NT$-16.26 Mil. Eusol Biotech Co's Revenue for the six months ended in Jun. 2024 was NT$0.00 Mil. Therefore, Eusol Biotech Co's EBITDA margin for the quarter that ended in Jun. 2024 was 0.00%.


Eusol Biotech Co EBITDA Margin % Historical Data

The historical data trend for Eusol Biotech Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eusol Biotech Co EBITDA Margin % Chart

Eusol Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only - - - - -

Eusol Biotech Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Eusol Biotech Co's EBITDA Margin %

For the Biotechnology subindustry, Eusol Biotech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eusol Biotech Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eusol Biotech Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Eusol Biotech Co's EBITDA Margin % falls into.



Eusol Biotech Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Eusol Biotech Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-44.951/0
= %

Eusol Biotech Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-16.257/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eusol Biotech Co  (ROCO:6652) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Eusol Biotech Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eusol Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Minsheng E. Road, 6th Floor, No.135, Sec.3, Songshan District, Taipei, TWN, 10546
Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co Headlines

No Headlines